Assessment of long-term safety and efficacy of Dupilumab therapy in patients with moderate-to-severe atopic dermatitis in the UAE: A real-life observational study
Pharmacy Practice · 08.10.2024 · 22 (2) · 1-11
DOI: 10.18549/pharmpract.2024.2.2947 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacy Practice, online erschienen am 08.10.2024. Verfasst von Waqas S. Abdulwahhab und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Abdulwahhab, W. S., ZainAlAbdin, S., Al-Areqi, N., Amrane, I., AlHashmi, A., AbuRuz, O., Akour, A., Beiram, R., & Aburuz, S. (2024). Assessment of long-term safety and efficacy of Dupilumab therapy in patients with moderate-to-severe atopic dermatitis in the UAE: A real-life observational study. Pharmacy Practice, 22(2), 1-11. https://doi.org/10.18549/pharmpract.2024.2.2947
Vancouver
Abdulwahhab WS, ZainAlAbdin S, Al-Areqi N, Amrane I, AlHashmi A, AbuRuz O, et al. Assessment of long-term safety and efficacy of Dupilumab therapy in patients with moderate-to-severe atopic dermatitis in the UAE: A real-life observational study. Pharmacy Practice. 2024;22(2):1-11. doi:10.18549/pharmpract.2024.2.2947
BibTeX
@article{Abdulwahhab2024,
author = {Abdulwahhab, Waqas S. and ZainAlAbdin, Sham and Al-Areqi, Noor and Amrane, Imene and AlHashmi, Ahmed and AbuRuz, Omar and Akour, Amal and Beiram, Rami and Aburuz, Salahdein},
title = {Assessment of long-term safety and efficacy of Dupilumab therapy in patients with moderate-to-severe atopic dermatitis in the UAE: A real-life observational study},
journal = {Pharmacy Practice},
year = {2024},
volume = {22},
number = {2},
pages = {1--11},
doi = {10.18549/pharmpract.2024.2.2947}
}
EUVIMED